Krystal Biotech buy The Goldman Sachs Group, Inc.
Start price
20.11.23
/
50%
€96.00
Target price
20.11.24
€146.38
Performance (%)
51.20%
Price
25.04.24
€145.15
Summary
This prediction is currently active. With a performance of 51.20% the BUY prediction by The_Goldman_Sachs_Gr is a big success. This prediction currently runs until 20.11.24. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | -2.420% | -2.420% |
| iShares Core DAX® | 2.594% | -1.861% |
| iShares Nasdaq 100 | 3.553% | -2.064% |
| iShares Nikkei 225® | 0.687% | -8.704% |
| iShares S&P 500 | 2.209% | -1.988% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $160.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat